Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to test whether an 8-week course of glucocorticoids,
combined with rituximab, is effective in treating ANCA-associated vasculitis.